HOUSTON, TEXAS June 19, 2008. Pharm-Olam International Ltd. (POI) a multi-national, full service CRO to pharmaceutical and biotech industries, welcomes the return of Helen Springford back to Pharm-Olam. Helen will serve as Vice President, Global Client Relations, where she will manage ongoing relationships with sponsors to help ensure their needs are met. Helen is based in POI’s European headquarters in the United Kingdom.

“Helen was instrumental in developing the BD department in the early days of Pharm-Olam and we welcome her return. Helen’s broad range of experience across the industry as a study site co-ordinator, manager of a SMO, research scientist for pharma, and as a project manager for CROs allows her to effectively manage complex studies”, said John Hovre, Chief Operating Officer at POI. Helen most recently held the post of Vice President of Global Business Development for a global CRO.

For further information about conducting trials with Pharm-Olam please contact Iain Gordon, Vice President of Business Development at iain.gordon@pharm-olam.com .

About Pharm-Olam International

Pharm-Olam International is a multi-national contract research organization offering a wide range of comprehensive, clinical research services to the pharmaceutical, biotechnology and medical device industries. From Phase I to Phase IV, POI focuses on delivering the highest quality data, achieving targeted enrollment and meeting projected timelines.